A novel HBV DNA vaccine based on T cell epitopes and its potential therapeutic effect in HBV transgenic mice

International Immunology

Volumn 17, Issue 10, 2005, Pages 1293-1302

  Li, Xiangming ^a   Yang, Xiaofeng ^a,b   Jiang, Yunyun ^a   Liu, Jing ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

DNA vaccine; HBV; Hsp70; T cell epitopes; Therapy

Indexed keywords

DNA VACCINE; EPITOPE; HEAT SHOCK PROTEIN 70; HEPATITIS B ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; PLASMID DNA; VIRUS DNA;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CHRONIC HEPATITIS; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA REPLICATION; DOWN REGULATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; FEASIBILITY STUDY; FEMALE; GENETIC CODE; HEPATITIS B; HEPATITIS B VIRUS; IMMUNOTHERAPY; MEDICAL RESEARCH; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE; VIRUS INHIBITION;

AMINO ACID SEQUENCE; ANIMALS; CELL PROLIFERATION; CYTOTOXICITY TESTS, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; FEMALE; GENETIC VECTORS; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS B VIRUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA;

EID: 27144447685     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxh305     Document Type: Article

References (39)

1. Lee, W. M. 1997. Hepatitis B virus infection. N. Engl. J. Med. 337:1733.
2. Straley, S. and Terrault, N. 2004. Overview of treatment of hepatitis B: key approaches and clinical challenges. Curr. Treat. Options Gastroenterol. 7:477.
3. Pianko, S. and McHutchison, J. 1999. Chronic hepatitis B: New therapies on the horizon. Lancet 354:1662.
4. Michel, M.-L., Pol, S., Brechot, C. and Tiollais, P. 2001. Immunotherapy of chronic hepatitis B by anti HBV vaccine: From present to future. Vaccine 19:2395.
5. Michel, M.-L. and Loirat, D. 2001. DNA Vaccines for prophylactic or therapeutic immunization against hepatitis B. Intervirology 44:78.
6. Couillin, I., Pol, S., Mancini, M. et al. 1999. Specific vaccine therapy in chronic hepatitis B: Induction of T cell proliferative responses specific for envelope antigens. J. Infect. Dis. 180:15.
7. Pol, S., Couillin, I., Michel, M. et al. 1998. Immunotherapy of chronic hepatitis B by anti HBV vaccine. Acta Gastroenterol. Belg. 61:228.
8. Yalcin, K., Danis, R., Degertekin, H., Alp, M. N., Tekes, S. and Buclak, T. 2003. The lack of effect of therapeutic vaccination with a Pre-S2/S HBV vaccine in the immune tolerant phase of chronic HBV infection. J. Clin. Gastroenterol. 37:330.
9. Swain, W., Heydenburg, F. D., Wu, M. et al. 2000. Tolerability and immune responses in humans to a PowderJect DNA vaccine for hepatitis B. Dev. Biol. (Basel) 104:115.
10. Roy, M. J., Wu, M. S., Barr, L. J. et al. 2001. Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis 6 virus DNA vaccine. Vaccine 19:764.
11. Mancini-Bourgine, M., Fontaine, H., Scott-Algara, D., Pol, S., Bréchot, C. and Michel, M.-L. 2004. Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers. Hepatology 40:874.
12. Fonseca, D. P. A. J., Benaissa-Trouw, B., Engelen, M. V., Kraaijeveld, C. A., Snippe, H. and Verhuel, A. F. M. 2001. Induction of cell-mediated immunity against Mycobacterium tuberculosis using DNA vaccines encoding cytotoxic and helper T-cell epitopes of the 38-kilodalton protein. Infect. Immun. 69:4839.
13. Suhrber, A. 2002. Polytope vaccines for the codelivery of multiple CD8 T-cell epitopes. Expert Rev. Vaccines 1:207.
14. Fomsgaard, A., Nielsena, H. V., Kirkbya, N. et al. 1999. Induction of cytotoxic T-cell responses by gene gun DNA vaccination with minigenes encoding influenza A virus HA and NP CTL-epitopes. Vaccine 18:681.
15. Toes, R. E. M., Hoeben, R. C., Van der Voort, E. I. H., Ressing, M. E., Meliet, C. J. M. and Offringa, R. 1997. Protective anti-tumor immunity induced by vaccination with recombinant adenoviruses encoding multiple tumor-associated cytotoxic T lymphocyte epitopes in a string-of-beads fashion. Proc. Natl Acad. Sci. USA 94:14660.
16. Bazhan, S. I., Belavin, P. A., Seregin, S. V. et al. 2004. Designing and engineering of DNA-vaccine construction encoding multiple CTL-epitopes of major HIV-1 antigens. Vaccine 22:1672.
17. Wilson, C. C., McKinney, D., Anders, M. et al. 2003. Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1. J. Immunol. 171:5611.
18. Subbramanian, R. A., Kuroda, M. J., Charini, W. A. et al. 2003. Magnitude and diversity of cytotoxic-T-lymphocyte responses elicited by multiepitope DNA vaccination in rhesus monkeys. J. Virol. 77:10113.
19. Ishioka, G. Y., Hermanson, J. F G., Livingston, B. et al. 1999. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes. J. Immunol. 162:3915.
20. Asea, A., Kraeft, S., Kurt-Jones, E. et al. 2000. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med. 6:435.
21. Srivastava, P. K. and Amato, R. J. 2001. Heat shock proteins: The 'Swiss Army Knife' vaccines against cancers and infectious agents. Vaccine 19:2590.
22. Gao, B. and Tsan, M.-F 2003. Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor release by murine macrophages. J. Biol. Chem. 278:174.
23. Bausinger, H., Lipsker, D., Ziylan, U. et al. 2002. Endotoxin-free heat-shock protein 70 fails to induce APC activation. Eur. J. Immunol. 32:3708.
24. Cheng, W., Hung, C., Lin, K. et al. 2003. CD8+ T cells, NK cells and IFN-gamma are important for control of tumor with down-regulated MHC class I expression by DNA vaccination. Gene Ther. 10:1311.
25. Huang, Q., Richmond, J. F. L., Suzue, K., Eisen, H. N. and Younga, R. A. 2000. In vivo cytotoxic T lymphocyte elicitation by mycobacterial heat shock protein 70 fusion proteins maps to a discrete domain and is CD4+ T cell independent. J. Exp. Med. 191:403.
26. Chen, C.-H., Wang, T.-L., Hung, C.-F. et al. 2000. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Res. 60:1035.
27. Schirmbeck, R., Fissolo, N., Chaplin, P. and Reimann, J. 2003. Enhanced priming of multispecific, murine CD8+ T cell responses by DNA vaccines expressing stress protein-binding polytope peptides. J. Immunol. 171:1240.
28. Sette, A. D., Oseroff, C., Sidney, J. et al. 2001. Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice. J. Immunol. 166:1389.
29. Schirmbeck, R., Zheng, X., Roggendorf, M. et al. 2001. Targeting murine immune responses to selected T cell- or antibody-defined determinants of the hepatitis B surface antigen by plasmid DNA vaccines encoding chimeric antigen. J. Immunol. 166:1405.
30. Wei, W.-Z., Ratner, S., Shibuya, T., Yoo, G. and Jani, A. 2001. Foreign antigenic peptides delivered to the tumor as targets of cytotoxic T cells. J. Immunol. Methods 258:141.
31. Livingston, B. D., Newman, M., Crimi, C., McKinney, D., Chesnut, R. and Sette, A. 2001. Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines. Vaccine 19:4652.
32. Thomson, S. A., Sherritt, M. A., Medveczky, J. et al. 1998. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination. J. Immunol. 160:1717.
33. Livingston, B., Crimi, C., Newman, M. et al. 2002. A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes. J. Immunol. 168:5499.
34. Schirmbeck, R., Stober, D., Kholy, S. E., Riedl, P. and Reimann, J. 2002. The immunodominant, Ld-restricted T cell response to hepatitis B surface antigen (HBsAg) efficiently suppresses T cell priming to multiple Dd-, Kd-, and Kb-restricted HBsAg epitopes. J. Immunol. 168:6253.
35. Chow, Y.-H., Chiang, B.-L., Lee, Y.-L. et al. 1998. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J. Immunol. 160:1320.
36. Lipsker, D., Ziylan, U., Spehner, D. et al. 2002. Heat shock proteins 70 and 60 share common receptors which are expressed on human monocyte-derived but not epidermal dendritic cells. Eur. J. Immunol. 32:322.
37. Basu, S., Binder, R., Ramalingam, T. and Srivastava, P. 2001. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14:303.
38. Mancini, M., Hadchouel, M., Tiollais, R and Michel, M.-L. 1998. Regulation of hepatitis B virus mRNA expression in a hepatitis B surface antigen transgenic mouse model by IFN-secreting T cells after DNA-based immunization. J. Immunol. 161:5564.
39. Whalley, S. A., Brown, D., Webster, G. J. et al. 2004. Evolution of hepatitis B virus during primary infection in humans: Transient generation of cytotoxic T-cell mutants. Gastroenterology 127:113.